Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia

Abstract We have previously identified differential effects of age on global brain gene expression profiles in subjects with schizophrenia compared to normal controls. Here, we have focused on age-related effects of genes associated with the arachidonic acid-related inflammation pathway. Linear correlation analysis of published microarray expression data reveal strong age- and cell-type- specific-effects on the expression of genes related to the arachidonic acid signaling pathway, which differed in control subjects compared to those with schizophrenia. Using real-time qPCR analysis, we validated age and disease effects of arachidonic acid-related genes in a large cohort of subjects with schizophrenia and matched controls ( n =76 subjects in total). We found that levels of prostaglandin-endoperoxide synthase 1 ( PTGS1 ; aka COX-1) and prostaglandin-endoperoxide receptor 3 ( PTGER3 ) mRNA are increased, and levels of prostaglandin-endoperoxide synthase 2 ( PTGS2 ; aka COX-2) mRNA are decreased, in older subjects with schizophrenia (>40years of age) compared to matched normal controls or younger subjects with schizophrenia (